Pathologic evaluation of malignant pleural mesothelioma

Area of Science:

• Oncology
• Pathology
• Thoracic Surgery

Background:

• Diffuse malignant pleural mesothelioma is a rare but aggressive cancer.
• Accurate diagnosis and staging are critical for effective surgical management and patient outcomes.

Purpose of the Study:

• To highlight the indispensable role of pathologists in the multidisciplinary care of malignant pleural mesothelioma.
• To detail the contributions of pathology to diagnosis, staging, and treatment guidance.

Main Methods:

• Review of pathological diagnostic criteria for pleural mesothelioma.
• Analysis of prognostic factors determined by pathologists (histologic subtype, tumor extent, margins, nodal status).
• Description of pathologist involvement in preoperative, intraoperative, and postoperative clinical decision-making.

Main Results:

• Pathologists provide definitive histologic subtyping, crucial for prognosis and treatment.
• Pathological assessment of resection margins and lymph node status directly impacts staging and further management.
• Pathology facilitates the monitoring of treatment response to chemotherapy.

Conclusions:

• Pathologists are central to the accurate diagnosis, staging, and prognostic assessment of malignant pleural mesothelioma.
• Pathological expertise is vital for guiding surgical and chemotherapeutic treatment strategies.
• Collaboration between pathologists and the clinical team optimizes patient care pathways for this disease.